Covid-19 DIB rapid site specific needle delivery adjustable vessel occlusion for control of junctional and non-compressible hemorrhage
Ended Definitive Contract Awarded Last action
- Contract number
- FA864920C0303
- Awardee
-
Amsel Medical Corporation UEI UUM9WLJWJQ24
- Awarding agency
-
Air Force Research Laboratory
Air Force Materiel Command, Department of Defense
- Obligated
- $999,981
Award facts
- Contract value 100% obligated
- $999,981.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 645 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
- Research
- SBIR Program Phase II Action
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $999,981 |
About this award
Amsel Medical Corporation has been awarded a definitive contract valued at approximately $1 million by the Department of the Air Force Materiel Command Research Laboratory. The firm fixed price contract is for the continued development of COVID-19 DIB RAPID SITE SPECIFIC NEEDLE DELIVERY ADJUSTABLE VESSEL OCCLUSION FOR CONTROL OF JUNCTIONAL AND NON-COMPRESSIBLE HEMORRHAGE under the Small Business Innovation Research Program Phase II Action. This total small business set aside contract will support research at Amsel's place of performance in Cambridge, Massachusetts through September 2022. No major subcontractors were identified. The award provides continued funding for Amsel's work developing medical technologies of national interest to the Department of Defense under the Air Force Materiel Command Research Laboratory's coronavirus response programs.
Quick answers
Who was awarded contract FA864920C0303?
FA864920C0303 was awarded to Amsel Medical Corporation by Air Force Research Laboratory (Air Force Materiel Command) on July 13, 2020.
How much is contract FA864920C0303 worth?
The government has obligated $999,981 on FA864920C0303.
Was contract FA864920C0303 competed?
The extent of competition for FA864920C0303 was full and open competition after exclusion of sources. The government received 645 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award